Ctt Pharmaceutical Holdings Stock Net Asset
| CTTH Stock | USD 0.06 0 6.19% |
CTT Pharmaceutical Holdings fundamentals help investors to digest information that contributes to CTT Pharmaceutical's financial success or failures. It also enables traders to predict the movement of CTT Pink Sheet. The fundamental analysis module provides a way to measure CTT Pharmaceutical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CTT Pharmaceutical pink sheet.
CTT |
CTT Pharmaceutical Holdings Company Net Asset Analysis
CTT Pharmaceutical's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current CTT Pharmaceutical Net Asset | 186.54 K |
Most of CTT Pharmaceutical's fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CTT Pharmaceutical Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
| Competition |
Based on the recorded statements, CTT Pharmaceutical Holdings has a Net Asset of 186.54 K. This is much higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The net asset for all United States stocks is notably lower than that of the firm.
CTT Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CTT Pharmaceutical's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of CTT Pharmaceutical could also be used in its relative valuation, which is a method of valuing CTT Pharmaceutical by comparing valuation metrics of similar companies.CTT Pharmaceutical is currently under evaluation in net asset category among its peers.
CTT Fundamentals
| Return On Equity | -4.49 | |||
| Return On Asset | -1.54 | |||
| Current Valuation | 18.87 M | |||
| Shares Outstanding | 21.32 M | |||
| Price To Earning | (3.00) X | |||
| Price To Book | 10.64 X | |||
| Revenue | 40 K | |||
| Net Income | (1.38 M) | |||
| Cash And Equivalents | 32.12 K | |||
| Total Debt | 87.62 K | |||
| Debt To Equity | 0.12 % | |||
| Current Ratio | 5.01 X | |||
| Book Value Per Share | 0.04 X | |||
| Cash Flow From Operations | (145.16 K) | |||
| Earnings Per Share | (0.08) X | |||
| Number Of Employees | 15 | |||
| Beta | 1.14 | |||
| Market Capitalization | 16.17 M | |||
| Total Asset | 186.54 K | |||
| Net Asset | 186.54 K |
About CTT Pharmaceutical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CTT Pharmaceutical Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CTT Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CTT Pharmaceutical Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in CTT Pink Sheet
CTT Pharmaceutical financial ratios help investors to determine whether CTT Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CTT with respect to the benefits of owning CTT Pharmaceutical security.